ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

US regulators clarify stance on CRISPR’d food – BioNews

Continue reading

2018-04-09 Michael Zand NEWS

Pfizer and Allogene Agree to Collaborate on Developing Donor-derived CAR T-cell Therapies – Immuno-Oncology News

US regulators clarify stance on CRISPR‘d food
BioNews
CRISPR greens may soon be served in the USA: the US Secretary of Agriculture, Sonny Perdue clarified the stance of the US Department of Agriculture (USDA) on crops that have been genome edited using the tool. Such plants can be developed and sold free …

Continue reading

2018-04-09 Michael Zand NEWS

Pfizer and Allogene Agree to Collaborate on Developing Donor-derived CAR T-cell Therapies – Immuno-Oncology News


Immuno-Oncology News

Pfizer and Allogene Agree to Collaborate on Developing Donor-derived CAR T-cell Therapies
Immuno-Oncology News
Pfizer and Allogene Therapeutics have entered into a contribution agreement for Pfizer’s portfolio of assets related to donor-derived chimeric antigen receptor T-cell (CAR T) therapy, a kind of cell therapy directed at blood cancers and solid tumors …
Allogene Therapeutics Completes Agreement for Pfizer’s Allogeneic CAR T Immuno-oncology PortfolioDigital Journal

all 82 news articles »

Continue reading

2018-04-09 Michael Zand NEWS

Novartis to buy AveXis in $8.7bn gene-therapy deal – Reuters

ReutersNovartis to buy AveXis in $8.7bn gene-therapy dealReutersNovartis to buy AveXis in $8.7bn gene-therapy deal. 7:00am EDT – 01:28. Swiss drugmaker Novartis is moving further into gene therapy by buying AveXis for $8.7 billion, adding a rare-diseas… Continue reading

2018-04-09 Michael Zand NEWS

Novartis to buy AveXis in $8.7bn gene-therapy deal – Reuters.com

Reuters.comNovartis to buy AveXis in $8.7bn gene-therapy dealReuters.comNovartis to buy AveXis in $8.7bn gene-therapy deal. Swiss drugmaker Novartis is moving further into gene therapy by buying AveXis for $8.7 billion, adding a rare-disease treatment … Continue reading

2018-04-09 Michael Zand NEWS

Advances in Bladder Cancer – Systemic Therapies Including Immunotherapy – Petros Grivas – UroToday

UroTodayAdvances in Bladder Cancer – Systemic Therapies Including Immunotherapy – Petros GrivasUroTodayPetros Grivas and Alicia Morgans discuss the progress in systemic and immunotherapy in advanced bladder cancer. They discuss the biologic and immunol… Continue reading

2018-04-09 Michael Zand NEWS

Global Synthetic Biology Market 2017 Top Players- Amyris, DuPont, GenScript USA, Intrexon, Integrated DNA … – The Financial Analyst

The Financial AnalystGlobal Synthetic Biology Market 2017 Top Players- Amyris, DuPont, GenScript USA, Intrexon, Integrated DNA …The Financial AnalystMarketNReports from its Database gives research study on “Synthetic Biology market” reports. It offer… Continue reading

2018-04-09 Michael Zand NEWS

It’s all about the (stem cell) neighborhood – Phys.Org


Business Wire (press release)

Pfizer and Allogene Agree to Collaborate on Developing Donor-derived CAR T-cell Therapies
Immuno-Oncology News
Pfizer and Allogene Therapeutics have entered into a contribution agreement for Pfizer’s portfolio of assets related to donor-derived chimeric antigen receptor T-cell (CAR T) therapy, a kind of cell therapy directed at blood cancers and solid tumors …
Allogene Therapeutics Completes Agreement for Pfizer’s Allogeneic CAR T Immuno-oncology PortfolioBusiness Wire (press release)

all 2 news articles »

Continue reading

2018-04-09 Michael Zand NEWS
  • 1
  • …
  • 279
  • 280
  • 281
  • 282
  • 283
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Phys.Org

It’s all about the (stem cell) neighborhood
Phys.Org
Stems cells in adult tissues live in very specific locations called stem cell niches. These niches provide a specialised, ideal neighbourhood for stem cells. The stem cells in the niche are undifferentiated, meaning they have not yet changed into …
It’s all about the (stem cell) neighborhood — ScienceDailyScience Daily
Are we on the brink of a stem cell revolution? – The TelegraphTelegraph.co.uk
Even after FDA warnings, stem cell clinics still turning hope into hypeAtlanta Journal Constitution
BioNews –Belarus News (BelTA)
all 27 news articles »